Caraco Pharmaceutical Laboratories, Ltd. engages in the development, manufacture, marketing, and distribution of generic, prescription, and over-the-counter pharmaceuticals for wholesalers, distributors, warehousing and non-warehousing chain drugstores, and managed care providers in the United States and Puerto Rico. It offers therapeutic drugs, such as analgesics, anorectics, antiallergics, antianxiety, antibiotics, anticonvulsants, antidepressants, antidiabetics, antiematics, anti-gouts, antihypertensive/beta blockers, antipsychotics, antithryoid agents, antitussive, anti ulcerants, bisphosphonate derivatives, calcium channel blockers, cardiac, decongestants, and narcotic analgesics. The company?s therapeutic drugs also include nonsteroidal antiinflammatory agents, opiate agonist/analgesics, oncology adjuncts, Parkinson?s disease, platelet aggregation inhibitors, sedatives and hypnotics, skeletal muscle relaxants, and vascular and migraine headache suppressants. It offers its products for central nervous system, cardiology, pain management, and diabetes. The company was founded in 1984 and is based in Detroit, Michigan. Caraco Pharmaceutical Laboratories, Ltd. is a subsidiary of Sun Pharmaceutical Industries Limited.